These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 18208365)

  • 1. Tissue-type plasminogen activator as a therapeutic target in stroke.
    Gravanis I; Tsirka SE
    Expert Opin Ther Targets; 2008 Feb; 12(2):159-70. PubMed ID: 18208365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
    Jin R; Xiao AY; Liu S; Wang M; Li G
    Stroke; 2018 Jul; 49(7):1708-1718. PubMed ID: 29844028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodents.
    Wang Y; Zhang Z; Chow N; Davis TP; Griffin JH; Chopp M; Zlokovic BV
    Stroke; 2012 Sep; 43(9):2444-9. PubMed ID: 22811462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.
    Merino-Zamorano C; Hernández-Guillamon M; Jullienne A; Le Béhot A; Bardou I; Parés M; Fernández-Cadenas I; Giralt D; Carrera C; Ribó M; Vivien D; Ali C; Rosell A; Montaner J
    Stroke; 2015 Feb; 46(2):477-84. PubMed ID: 25503547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.
    Adibhatla RM; Hatcher JF
    CNS Neurol Disord Drug Targets; 2008 Jun; 7(3):243-53. PubMed ID: 18673209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2000 Dec; 31(12):3034-40. PubMed ID: 11108768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Strategies to Attenuate Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke.
    Kanazawa M; Takahashi T; Nishizawa M; Shimohata T
    J Atheroscler Thromb; 2017 Mar; 24(3):240-253. PubMed ID: 27980241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of tissue plasminogen activator factor in an acute stroke patient with two unruptured cerebral aneurysms.
    Sonbaa AM; Khayat AF; Almekhlafi MA
    Neurosciences (Riyadh); 2018 Oct; 23(4):334-337. PubMed ID: 30351292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
    Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
    Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycemia, acute ischemic stroke, and thrombolytic therapy.
    Hafez S; Coucha M; Bruno A; Fagan SC; Ergul A
    Transl Stroke Res; 2014 Aug; 5(4):442-453. PubMed ID: 24619488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ischemic stroke during intravenous recombinant tissue plasminogen activator infusion for evolving myocardial infarction.
    Chang GY
    Eur J Neurol; 2001 May; 8(3):267-8. PubMed ID: 11328336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
    Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
    Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Teoh HL; Chan BP
    Expert Rev Neurother; 2012 Feb; 12(2):209-17. PubMed ID: 22288676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocycline.
    Hess DC; Fagan SC
    Pharmacotherapy; 2010 Jul; 30(7 Pt 2):55S-61S. PubMed ID: 20575623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?
    Niego B; Medcalf RL
    J Cereb Blood Flow Metab; 2014 Aug; 34(8):1283-96. PubMed ID: 24896566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.
    Liu S; Feng X; Jin R; Li G
    Expert Opin Drug Deliv; 2018 Feb; 15(2):173-184. PubMed ID: 28944694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
    Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ;
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of air medical transportation after tissue plasminogen activator administration in acute ischemic stroke.
    Chalela JA; Kasner SE; Jauch EC; Pancioli AM
    Stroke; 1999 Nov; 30(11):2366-8. PubMed ID: 10548672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.